The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors
Abstract Tumor-infiltrated lymphocytes are exposed to many toxic metabolites and molecules in the tumor microenvironment (TME) that suppress their anti-tumor activity. Toxic metabolites, such as lactate and ketone bodies, are produced mainly by catabolic cancer-associated fibroblasts (CAFs) to feed...
Main Authors: | Samaneh Mostafavi, Hamidreza Zalpoor, Zuhair Mohammad Hassan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Cellular & Molecular Biology Letters |
Subjects: | |
Online Access: | https://doi.org/10.1186/s11658-022-00356-2 |
Similar Items
-
Metformin: When Should We Fear Lactic Acidosis?
by: Stefania Di Mauro, et al.
Published: (2022-07-01) -
Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
by: Demin Cheng, et al.
Published: (2021-08-01) -
Cancer-Associated Fibroblasts in Oral Cancer: A Current Perspective on Function and Potential for Therapeutic Targeting
by: Kamila J. Bienkowska, et al.
Published: (2021-07-01) -
Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target
by: Akira Orimo, et al.
Published: (2013-01-01) -
Mechanical and Physical Regulation of Fibroblast–Myofibroblast Transition: From Cellular Mechanoresponse to Tissue Pathology
by: Mirko D'Urso, et al.
Published: (2020-12-01)